Evidence map›Paper›PMID 38983060›Full record

ArticleFrontiers in ophthalmology2023

Mitochondrial DNA

Antoni Vallbona-Garcia, Patrick J Lindsey, Rick Kamps, Alphons P M Stassen, Nhan Nguyen, Florence H J van Tienen, Ilse H J Hamers, Rianne Hardij, Marike W van Gisbergen, Birke J Benedikter and 4 more

Abstract read
In one paragraph

Article in Frontiers in ophthalmology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Antoni Vallbona-GarciaUniversity Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, Netherlands.
Patrick J LindseyDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Rick KampsDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Alphons P M StassenDepartment of Clinical Genetics, Maastricht University Medical Center, Maastricht, Netherlands.
Nhan NguyenDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Florence H J van TienenDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Ilse H J HamersDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Rianne HardijDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Marike W van GisbergenDepartment of Dermatology, Maastricht University Medical Center, Maastricht, Netherlands.
Birke J BenedikterUniversity Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, Netherlands.
Irenaeus F M de CooDepartment of Toxicogenomics, Maastricht University, Maastricht, Netherlands.
Carroll A B WebersUniversity Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, Netherlands.
Theo G M F Gorgels *University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, Netherlands.
Hubert J M Smeets *Department of Toxicogenomics, Maastricht University, Maastricht, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Primary open-angle glaucoma (POAG) is a characteristic optic neuropathy, caused by degeneration of the optic nerve-forming neurons, the retinal ganglion cells (RGCs). High intraocular pressure (IOP) and aging have been identified as major risk factors; yet the POAG pathophysiology is not fully understood. Since RGCs have high energy requirements, mitochondrial dysfunction may put the survivability of RGCs at risk. We explored in buffy coat DNA whether mtDNA variants and their distribution throughout the mtDNA could be risk factors for POAG. Methods: The mtDNA was sequenced from age- and sex-matched study groups, being high tension glaucoma (HTG, n=71), normal tension glaucoma patients (NTG, n=33), ocular hypertensive subjects (OH, n=7), and cataract controls (without glaucoma; n=30), all without remarkable comorbidities. Results: No association was found between the number of mtDNA variants in genes encoding proteins, tRNAs, rRNAs, and in non-coding regions in the different study groups. Next, variants that controls shared with the other groups were discarded. A significantly higher number of exclusive variants was observed in the D-loop region for the HTG group (~1.23 variants/subject), in contrast to controls (~0.35 variants/subject). In the D-loop, specifically in the 7S DNA sub-region within the Hypervariable region 1 (HV1), we found that 42% of the HTG and 27% of the NTG subjects presented variants, while this was only 14% for the controls and OH subjects. As we have previously reported a reduction in mtDNA copy number in HTG, we analysed if specific D-loop variants could explain this. While the majority of glaucoma patients with the exclusive D-loop variants m.72T>C, m.16163 A>G, m.16186C>T, m.16298T>C, and m.16390G>A presented a mtDNA copy number below controls median, no significant association between these variants and low copy number was found and their possible negative role in mtDNA replication remains uncertain. Approximately 38% of the HTG patients with reduced copy number did not carry any exclusive D-loop or other mtDNA variants, which indicates that variants in nuclear-encoded mitochondrial genes, environmental factors, or aging might be involved in those cases. Conclusion: In conclusion, we found that variants in the D-loop region may be a risk factor in a subgroup of POAG, possibly by affecting mtDNA replication.

Indexed as

D-loop (control region)glaucomamitochondriamtDNAmtDNA replicationPOAG

Identifiers

PMID38983060
PMCPMC11182222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.